Race/ethnicity is independently associated with initiating any anticoagulant therapy and direct-acting oral anticoagulant use among anticoagulant initiators for Veterans Health Administration (VA) patients with incident atrial fibrillation.
For Medicare beneficiaries with implantable cardioverter defibrillators (ICDs), physical activity (PA) is associated with a reduction in all-cause mortality.
For older adults with atrial fibrillation, apixaban is associated with lower rates of adverse events than warfarin across all frailty levels.
Study investigators assessed the impact of acute heart failure on long-term adverse outcomes among patients who present to the emergency department with atrial fibrillation.
Investigators evaluated mortality associated with atrial fibrillation in heart failure.
Neither marine omega-3 fatty acids, EPA and DHA, nor vitamin D3 are associated with a reduction in the risk for incident atrial fibrillation.
ACC policy position statement on prioritization and allocation of COVID-19 vaccine focuses on cardiovascular disease.
Rates of atrial tachyarrhythmia recurrence were found to be lower in patients receiving catheter cryoballoon ablation vs antiarrhythmic pharmacotherapy as first-line intervention for treatment-naive, symptomatic, paroxysmal atrial fibrillation.
AHA issued Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
Arrhythmia-free survival after catheter ablation for atrial fibrillation was comparable in patients with heart failure with preserved and reduced ejection fraction.
